0001209191-23-047348.txt : 20230825
0001209191-23-047348.hdr.sgml : 20230825
20230825164544
ACCESSION NUMBER: 0001209191-23-047348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230824
FILED AS OF DATE: 20230825
DATE AS OF CHANGE: 20230825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Palmer Pamela P
CENTRAL INDEX KEY: 0001511365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 231209006
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-24
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001511365
Palmer Pamela P
C/O ACELRX PHARMACEUTICALS, INC.
1850 GATEWAY DRIVE, SUITE 175
SAN MATEO
CA
94404
1
1
0
0
Chief Medical Officer
0
Common Stock
2023-08-24
4
S
0
9514
1.17
D
38195
D
Common Stock
2023-08-25
4
S
0
7442
1.089
D
30753
D
The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.17 to $1.19 on August 24, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price.
Balance includes non-reportable acquisition of 4,394 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023.
/s/ Martha Adler. Attorney-In-Fact
2023-08-25